ArticleCardiovascular diabetology2004
Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both?
Alexander Tenenbaum et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it